CERIBELL INC (CBLL) Stock Price & Overview
NASDAQ:CBLL • US15678C1027
The current stock price of CBLL is 17.77 USD. Today CBLL is up by 1.31%. In the past month the price decreased by -13.23%. In the past year, price decreased by -21.68%.
CBLL Key Statistics
- Market Cap
- 668.863M
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- -1.47
- Dividend Yield
- N/A
CBLL Stock Performance
CBLL Stock Chart
CBLL Technical Analysis
ChartMill assigns a technical rating of 0 / 10 to CBLL. When comparing the yearly performance of all stocks, CBLL is a bad performer in the overall market: 82.62% of all stocks are doing better.
CBLL Fundamental Analysis
ChartMill assigns a fundamental rating of 4 / 10 to CBLL. CBLL scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.
CBLL Earnings
On February 24, 2026 CBLL reported an EPS of -0.36 and a revenue of 24.78M. The company beat EPS expectations (14.41% surprise) and beat revenue expectations (1.49% surprise).
CBLL Forecast & Estimates
14 analysts have analysed CBLL and the average price target is 28.71 USD. This implies a price increase of 61.54% is expected in the next year compared to the current price of 17.77.
For the next year, analysts expect an EPS growth of -1.3% and a revenue growth 28.3% for CBLL
CBLL Groups
Sector & Classification
CBLL Financial Highlights
Over the last trailing twelve months CBLL reported a non-GAAP Earnings per Share(EPS) of -1.47. The EPS decreased by -29.54% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -27.28% | ||
| ROE | -34.38% | ||
| Debt/Equity | 0.13 |
CBLL Ownership
CBLL Latest News, Press Relases and Analysis
CBLL Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 19.7 | 196.666B | ||
| ISRG | INTUITIVE SURGICAL INC | 49.03 | 177.984B | ||
| SYK | STRYKER CORP | 25.26 | 146.042B | ||
| BSX | BOSTON SCIENTIFIC CORP | 20.62 | 107.089B | ||
| IDXX | IDEXX LABORATORIES INC | 43.78 | 51.799B | ||
| EW | EDWARDS LIFESCIENCES CORP | 28.66 | 49.453B | ||
| BDX | BECTON DICKINSON AND CO | 10.88 | 48.859B | ||
| RMD | RESMED INC | 21.1 | 37.738B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 15.73 | 36.013B | ||
| DXCM | DEXCOM INC | 28.87 | 28.433B | ||
| ZBH | ZIMMER BIOMET HOLDINGS INC | 11.18 | 18.976B | ||
| PODD | INSULET CORP | 38.31 | 17.087B | ||
| HOLX | HOLOGIC INC | 15.04 | 16.893B |
Related stock screener links
View all stocks in the Health Care Equipment Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About CBLL
Company Profile
Ceribell, Inc. is a commercial-stage medical technology company, which engages in the provision of transforming the diagnosis and management of patients with serious neurological conditions. The company is headquartered in Sunnyvale, California and currently employs 327 full-time employees. The company went IPO on 2024-10-11. The firm has developed the Ceribell System, a point-of-care electroencephalography (EEG) platform specifically designed to address the unmet needs of patients in the acute care setting. By combining highly portable and rapidly deployable hardware with artificial intelligence-powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions. The Ceribell System is FDA-cleared (510(k)) for indicating suspected seizure activity and utilized in intensive care units and emergency rooms across the United States. Clarity, its machine learning algorithm, continuously interprets a patient’s EEG waveforms and displays actionable insights regarding seizure activity on the recorder. Its EEG portal is a cloud-based portal that enables real-time remote access to a patient’s EEG data.
Company Info
CERIBELL INC
360 N. Pastoria Avenue
Sunnyvale CALIFORNIA US
Employees: 327
Phone: 18004360826
CERIBELL INC / CBLL FAQ
Can you describe the business of CERIBELL INC?
Ceribell, Inc. is a commercial-stage medical technology company, which engages in the provision of transforming the diagnosis and management of patients with serious neurological conditions. The company is headquartered in Sunnyvale, California and currently employs 327 full-time employees. The company went IPO on 2024-10-11. The firm has developed the Ceribell System, a point-of-care electroencephalography (EEG) platform specifically designed to address the unmet needs of patients in the acute care setting. By combining highly portable and rapidly deployable hardware with artificial intelligence-powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions. The Ceribell System is FDA-cleared (510(k)) for indicating suspected seizure activity and utilized in intensive care units and emergency rooms across the United States. Clarity, its machine learning algorithm, continuously interprets a patient’s EEG waveforms and displays actionable insights regarding seizure activity on the recorder. Its EEG portal is a cloud-based portal that enables real-time remote access to a patient’s EEG data.
What is the stock price of CERIBELL INC today?
The current stock price of CBLL is 17.77 USD. The price increased by 1.31% in the last trading session.
What is the dividend status of CERIBELL INC?
CBLL does not pay a dividend.
What is the ChartMill rating of CERIBELL INC stock?
CBLL has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 4 out of 10.
What is the analyst forecast for CBLL stock?
14 analysts have analysed CBLL and the average price target is 28.71 USD. This implies a price increase of 61.54% is expected in the next year compared to the current price of 17.77.
What is the Price/Earnings (PE) ratio of CERIBELL INC (CBLL)?
CERIBELL INC (CBLL) does not have a PE ratio as the earnings reported over the last twelve months were negative (-1.47).
Can you provide the short interest for CBLL stock?
The outstanding short interest for CERIBELL INC (CBLL) is 5.75% of its float.